Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial
(Q36934269)
scientific article published on 15 June 2009
scientific article published on 15 June 2009
Language: